Overview

Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
To measure how frequently and to what degree a complication of transplant cell acute graft versus host disease (GvHD) occurs.
Phase:
Phase 2
Details
Lead Sponsor:
Stanford University
Treatments:
Antilymphocyte Serum
Cyclosporine
Cyclosporins
Lenograstim
Mycophenolate mofetil
Mycophenolic Acid
Sargramostim
Thymoglobulin